Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.7M Buy
+106,200
New +$28.7M 0.06% 270
2025
Q4
Sell
-12,100
Closed -$3.41M 3547
2025
Q3
$3.41M Buy
12,100
+800
+7% +$209K 0.01% 857
2025
Q2
$3.33M Sell
11,300
-15,100
-57% -$3.89M 0.01% 700
2025
Q1
$6.56M Buy
+26,400
New +$6.46M 0.04% 342
2023
Q4
Sell
-7,600
Closed -$1.07M 2659
2023
Q3
$1.07M Buy
+7,600
New +$1.08M 0.01% 936
2022
Q4
Sell
-3,300
Closed -$392K 2762
2022
Q3
$392K Buy
+3,300
New +$433K ﹤0.01% 1823
2022
Q1
Sell
-13,900
Closed -$1.86M 3425
2021
Q4
$1.86M Buy
+13,900
New +$1.74M 0.01% 704
2020
Q3
Sell
-2,406
Closed -$277K 2099
2020
Q2
$277K Sell
2,406
-3,347
-58% -$389K 0.01% 1021
2020
Q1
$610K Buy
+5,753
New +$728K 0.04% 350
2019
Q4
Sell
-11,715
Closed -$1.63M 1374
2019
Q3
$1.63M Buy
+11,715
New +$1.58M 0.08% 222

Other funds holding IBM

HRT Financial's IBM Position: Q1 2026 in Review

HRT Financial sold out of IBM (IBM) in Q1 2026, closing a stake of 62,499 shares — an estimated $16.9M sold.

HRT Financial first reported a position in IBM in Q2 2019 and held it in 10 quarters. The position peaked at $88.1M in Q1 2023. 3,463 funds tracked by Wall St. Rank hold IBM as of Q1 2026.

  • HRT Financial reported no remaining IBM position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 62,499 IBM shares in Q1 2026, an estimated $16.9M.
  • HRT Financial first reported a position in IBM in Q2 2019 and held it in 10 quarters.
  • HRT Financial's IBM position peaked at $88.1M in Q1 2023.
  • 3,463 funds tracked by Wall St. Rank held IBM as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.